Notice of Application to Register a Trade Name Product (Notice No. MPI 1068)
Maree Zinzley, Manager Approvals Operations, of the Ministry for Primary Industries (MPI), acting under delegated authority from the Director-General of MPI, gives notice under section 14(1) of the Agricultural Compounds and Veterinary Medicines Act 1997 (“Act”) that the following application has been made to register a trade name product under section 9(1) of the Act:
Trade Name: Lactium
Reference: A11745-01
Active Ingredient and Concentration:
Alpha-S1 casein trypsic hydolysate (alpha-cazosepine)
Formulation Type: Powder
General Use Claim:
To help maintain emotional balance. To assist with managing difficult/stressful situations.
Additional Information:
To be included in the diet of cats and dogs.
Any person may make a written submission to the director-general concerning this application.
Under sections 16 and 17 of the Act, a written submission:
Under section 18 of the Act, a copy of every submission will be forwarded to the applicant for the applicant’s information.
The following address is:
ACVM Group, Ministry for Primary Industries, Charles Fergusson Building, 34–38 Bowen Street, Pipitea, Wellington 6011. Postal Address: PO Box 2526, Wellington 6140.
The applicant’s address for service is:
Royal Canin Pty Limited, Building 14, 666 Great South Road, Penrose, Auckland. Postal Address: Level 23, Tower 1 Collins Square, Docklands, Victoria, Australia.
Dated at Wellington this 12th day of September 2019.
MAREE ZINZLEY, Manager Approvals Operations, Ministry for Primary Industries (acting under delegated authority).